| Heart Failure (HF) |
1 |
0.85 |
| SGLT2 Inhibitor |
0 |
0.78 |
| Acute Heart Failure (HF) |
0 |
0.72 |
| Cardiovascular Imaging |
0 |
0.67 |
| Type 2 Diabetes Mellitus |
0 |
0.62 |
| Heart |
0 |
0.56 |
| Nucleoside Reverse Transcriptase Inhibitors |
0 |
0.46 |
| Antiretroviral Therapy for HIV Infection |
0 |
0.44 |
| HIV Infection |
0 |
0.44 |
| Decompensated Heart Failure |
0 |
0.43 |
| Hypertension |
0 |
0.43 |
| Hospital |
0 |
0.35 |
| Ejection Fraction |
0 |
0.3 |
| Arizona |
0 |
0.2 |
| Medical Life |
0 |
0.15 |
| Clinical Guidelines |
0 |
0.1 |
| Match |
0 |
0.1 |
| Quality of Life |
0 |
0.1 |
| Renal Failure |
0 |
0.08 |
| Acute Kidney Injury |
0 |
0.05 |
| Beta Blockers |
0 |
0.05 |
| California |
0 |
0.05 |
| Clinical Research |
0 |
0.05 |
| Clinician Health and Well-Being |
0 |
0.05 |
| Diuretics |
0 |
0.05 |
| Receptors |
0 |
0.05 |